Beneficial effect of octreotide treatment in acute pancreatitis in rats

Int J Pancreatol. 1998 Dec;24(3):203-10. doi: 10.1007/BF02788423.

Abstract

Conclusions: Octreotide treatment contributes to the regulation of tumor necrosis factor (TNF) production in sodium taurocholate-induced acute necrotizing pancreatitis in rats. Owing to its complex effect, octreotide can partially ameliorate the deleterious consequences of acute necrotizing pancreatitis. Elevated TNF and interleukin-6 (IL-6) levels in the peritoneal fluid may be considered a consequence of the activation of peritoneal macrophages.

Background: The effects of octreotide on exocrine pancreatic function have been investigated in numerous studies, but little attention has been paid to its influence on cytokine production in acute pancreatitis.

Methods: Acute pancreatitis was induced by the retrograde injection of taurocholic acid into the pancreatic duct in male Wistar rats. Serum amylase activity, wet pancreatic weight/body weight (pw/bw) ratio, and TNF and IL-6 levels were measured. Four micrograms/kg of octreotide was administered subcutaneously at the time of induction of pancreatitis and 24 or 48 h later. Rats were sacrificed 6, 24, 48, or 72 h after the operation.

Results: The serum amylase level and pancreatic weight to body weight ratio were decreased significantly in the octreotide-treated group. The serum TNF level was decreased significantly in the octreotide-treated group as compared with the control group at 6, 24, and 48 h (0.6 +/- 1.5, 2.0 +/- 3.3, and 0 vs 50 +/- 15.5, 37.5 +/- 18.4, and 13.1 +/- 12.5 U/mL, respectively). The ascites TNF level was decreased to 0 in the octreotide-treated group and was elevated in the control group at 72 h (28.0 +/- 49.0 U/mL). IL-6 production in ascites was extremely high in both groups at 6 h (80,000 +/- 43,817 pg/mL and 58,500 +/- 33,335 pg/mL), but the difference was not significant.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amylases / blood
  • Animals
  • Ascitic Fluid / metabolism
  • Disease Models, Animal
  • Gastrointestinal Agents / therapeutic use*
  • Interleukin-6 / blood
  • Interleukin-6 / metabolism
  • Macrophage Activation
  • Male
  • Octreotide / therapeutic use*
  • Pancreatitis, Acute Necrotizing / drug therapy*
  • Pancreatitis, Acute Necrotizing / etiology
  • Pancreatitis, Acute Necrotizing / physiopathology
  • Rats
  • Rats, Wistar
  • Taurocholic Acid / administration & dosage
  • Taurocholic Acid / toxicity
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Gastrointestinal Agents
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Taurocholic Acid
  • Amylases
  • Octreotide